# Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar

> **NCT02777970** · PHASE4 · COMPLETED · sponsor: **Menarini Group** · enrollment: 654 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Tramadol Hydrochloride/Dexketoprofen Trometamol
- **DRUG:** Tramadol Hydrochloride/Paracetamol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02777970
- **Lead sponsor:** Menarini Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-02-14
- **Final completion:** 2017-02-14
- **Target enrollment:** 654 (ACTUAL)
- **Last updated:** 2021-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02777970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02777970, "Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02777970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*